Eli Lilly and Company
LLY
$1,017.97
-$34.02-3.23%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.61% | 13.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.61% | 13.13% | |||
| Cost of Revenue | 12.08% | 22.90% | |||
| Gross Profit | 9.10% | 11.31% | |||
| SG&A Expenses | 31.63% | -0.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.81% | 7.94% | |||
| Operating Income | 1.90% | 19.28% | |||
| Income Before Tax | 14.29% | 6.73% | |||
| Income Tax Expenses | -1.30% | 47.85% | |||
| Earnings from Continuing Operations | 18.90% | -1.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.90% | -1.38% | |||
| EBIT | 1.90% | 19.28% | |||
| EBITDA | 3.09% | 17.95% | |||
| EPS Basic | 18.76% | -1.27% | |||
| Normalized Basic EPS | 8.24% | 20.53% | |||
| EPS Diluted | 19.03% | -1.27% | |||
| Normalized Diluted EPS | 8.47% | 20.53% | |||
| Average Basic Shares Outstanding | 0.12% | -0.11% | |||
| Average Diluted Shares Outstanding | -0.09% | -0.11% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.16% | 0.01% | |||